文献速递青光眼

苦参碱降低皮质类固醇诱导的高眼压小鼠眼压

Matrine Reduces Intraocular Pressure in Corticosteroid-Induced Ocular Hypertensive Mouse Eyes.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

本研究在野生型C57BL/6小鼠中观察苦参碱对正常眼压及地塞米松-21-醋酸酯诱导的高眼压(OHT)模型的影响,发现50-200 µg/g苦参碱剂量依赖性降低正常小鼠眼压,100和200 µg/g可降低OHT小鼠眼压并增加房水流出易度,100 µg/g可增大前房角开放距离。

要点

  • 苦参碱(50-200 µg/g)剂量依赖性降低正常小鼠眼压。
  • 苦参碱(100和200 µg/g)降低DEX诱导OHT小鼠眼压并增加房水流出易度。
  • 100 µg/g苦参碱增大前房角开放距离,但未显著改变小梁网形态或相关标志物表达。

核心结论

  • 苦参碱降低DEX诱导OHT小鼠模型的眼压,提示其作为青光眼治疗药物的潜力,尤其是皮质类固醇相关的继发性病例。

研究设计与样本

  • 野生型C57BL/6小鼠随机分为正常组和OHT组,OHT模型通过球结膜穹窿注射地塞米松-21-醋酸酯建立。
  • 在苦参碱治疗后0.0、0.5、1.0、3.0和6.0小时测量两组眼压。
  • 采用既往描述/验证的灌注系统测量房水流出易度,前节光学相干断层扫描评估前房形态变化,苏木精-伊红染色和免疫荧光染色观察结构变化。

主要发现

  • 苦参碱(50-200 µg/g)剂量依赖性降低正常小鼠眼压。
  • 正常小鼠苦参碱(100和200 µg/g)治疗后0.5小时房水流出易度升高。
  • 100 µg/g苦参碱增加前房角开放距离。
  • DEX诱导OHT小鼠中,苦参碱(100和200 µg/g)降低升高的眼压并增加房水流出易度。
  • 与PBS对照相比,100 µg/g苦参碱增加前房角开放距离;但100 µg/g苦参碱在OHT小鼠治疗后0.5小时未引起小梁网大体形态或细胞收缩性及细胞外基质标志物表达的显著变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study investigates the potential of matrine, a quinolizidine alkaloid, in regulating intraocular pressure (IOP) in normal and corticosteroid-induced ocular hypertension (OHT) mice. METHODS: Wild-type C57BL/6 mice were randomly divided into normal and OHT groups. The OHT mouse model was established by periocular conjunctival fornix injections of dexamethasone-21-acetate (DEX). IOP was measured at 0.0, 0.5, 1.0, 3.0, and 6.0 hours after matrine treatment in both groups. Aqueous humor (AH) outflow facility was measured using our previously described/validated perfusion system. Anterior segment-optical coherence tomography was used to evaluate morphological changes in the anterior chamber following matrine treatment. Hematoxylin and eosin staining and immunofluorescence staining were used to investigate structural changes. RESULTS: Matrine treatment (50-200 µg/g) decreased the IOP in normal mice in a dose-dependent manner. AH outflow facility in normal mice elevated at 0.5 hours after matrine treatment (100 and 200 µg/g). Additionally, 100 µg/g matrine treatment increased the angle opening distance in the anterior chamber. In DEX-induced OHT mice, matrine (100 and 200 µg/g) reduced the elevated IOP and increased the AH outflow facility. Furthermore, 100 µg/g matrine treatment increased the angle opening distance compared with that of PBS-treated controls. However, matrine (100 µg/g) did not induce significant changes in trabecular meshwork gross morphology or the expression of cell contractility and extracellular matrix markers in OHT mice at 0.5 hours after treatment. CONCLUSIONS: Matrine decreased the IOP in the DEX-induced OHT mouse model, highlighting its potential as a therapeutic agent for managing glaucoma, particularly in corticosteroid-associated secondary cases.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zhang Q, Liu Z, Chen S, et al. Matrine Reduces Intraocular Pressure in Corticosteroid-Induced Ocular Hypertensive Mouse Eyes. Invest Ophthalmol Vis Sci. 2025. PMID: 40772663. doi:10.1167/iovs.66.11.18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。